Key result
Two cases of late stent thrombosis developed more than 4 years after intracoronary brachytherapy despite the use of combined antiplatelet therapy.
Case Report (n=2)
Highlights the risk of very late stent thrombosis (>4 years) following intracoronary brachytherapy even with combined antiplatelet therapy.
Very late stent thrombosis may occur >4 years after brachytherapy despite dual antiplatelet therapy; hypothesis-generating for extended surveillance needs.
Stent thrombosis is generally a fatal complication after percutaneous coronary intervention. Combined antiplatelet therapy is recommended to prevent stent thrombosis in those patients who have undergone stenting. However, there are conflicting opinions on the appropriate duration of instituting antiplatelet treatment, especially after intracoronary radiation therapy or drug-eluting stent implantation, which are two situations closely associated with an increased risk of stent thrombosis. We report here on 2 cases of late stent thrombosis that occurred despite giving combined antiplatelet therapy, and these maladies developed more than 4 years after intracoronary brachytherapy. (Korean Circulation J 2006;36:324-327)
No takes yet. Share an insight, caveat, or question.
Shin et al. (2006) conducted a case report in Late stent thrombosis (n=2). Intracoronary brachytherapy and combined antiplatelet therapy was evaluated on Late stent thrombosis. Two cases of late stent thrombosis developed more than 4 years after intracoronary brachytherapy despite the use of combined antiplatelet therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: